Skye Bioscience (SKYE) Price to Book (2015 - 2026)

Skye Bioscience (SKYE) has reported Price to Book for 12 consecutive years, with 6.1 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book fell 1384.7% year-over-year to 6.1 in Q2 2026; TTM through Jun 2026 was 6.1, a 1384.7% decrease from a year earlier, with the FY2025 full-year figure at 0.16, down 2.8% from the prior year.
• Price to Book was 6.1 for Q2 2026 at Skye Bioscience, down from 0.3 in the prior quarter.
• Over five years, Price to Book peaked at 2.38 in Q3 2023 and troughed at 7.19 in Q2 2022.
• A 5-year average of 0.53 and a median of 0.16 in 2024 frame the typical range for Price to Book.
• Across the five-year window, Price to Book jumped 584.38% in 2023 and tumbled 1384.7% in 2026, its largest moves.
• Over 5 years, Price to Book stood at 0.37 in 2022, then plunged by 202.66% to 1.12 in 2023, then soared by 114.39% to 0.16 in 2024, then declined by 2.8% to 0.16 in 2025, then tumbled by 4000.35% to 6.1 in 2026.
• The last three Price to Book figures came in at 6.1 (Q2 2026), 0.3 (Q1 2026), and 0.16 (Q4 2025), per Business Quant data.